S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:TKNO

Alpha Teknova (TKNO) Stock Price, News & Analysis

$2.65
+0.19 (+7.72%)
(As of 03/28/2024 ET)
Today's Range
$2.40
$2.72
50-Day Range
$2.41
$3.53
52-Week Range
$1.62
$4.27
Volume
15,480 shs
Average Volume
13,210 shs
Market Capitalization
$107.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TKNO stock logo

About Alpha Teknova Stock (NASDAQ:TKNO)

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.

TKNO Stock Price History

TKNO Stock News Headlines

Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Recap: Alpha Teknova Q4 Earnings
Earnings Preview: Alpha Teknova
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Alpha Teknova Insiders Land Bargain With Gains Of US$1.4m
Alpha Teknova: Q3 Earnings Insights
Alpha Teknova Inc TKNO
Teknova Announces New Board Member, Martha J. Demski
Teknova Reports Second Quarter 2023 Financial Results
See More Headlines
Receive TKNO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alpha Teknova and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2021
Today
3/28/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic substances
Sub-Industry
N/A
Current Symbol
NASDAQ:TKNO
Fax
N/A
Employees
285
Year Founded
N/A

Profitability

Net Income
$-36,780,000.00
Net Margins
-100.26%
Pretax Margin
-109.53%

Debt

Sales & Book Value

Annual Sales
$36.68 million
Book Value
$3.56 per share

Miscellaneous

Free Float
34,537,000
Market Cap
$107.93 million
Optionable
Not Optionable
Beta
0.25
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

TKNO Stock Analysis - Frequently Asked Questions

Should I buy or sell Alpha Teknova stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alpha Teknova in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TKNO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TKNO, but not buy additional shares or sell existing shares.
View TKNO analyst ratings
or view top-rated stocks.

How have TKNO shares performed in 2024?

Alpha Teknova's stock was trading at $3.73 at the beginning of 2024. Since then, TKNO stock has decreased by 29.0% and is now trading at $2.65.
View the best growth stocks for 2024 here
.

When is Alpha Teknova's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our TKNO earnings forecast
.

How were Alpha Teknova's earnings last quarter?

Alpha Teknova, Inc. (NASDAQ:TKNO) issued its quarterly earnings data on Tuesday, November, 9th. The company reported ($0.12) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.12). The firm had revenue of $9.39 million for the quarter, compared to analysts' expectations of $8 million. Alpha Teknova had a negative net margin of 100.26% and a negative trailing twelve-month return on equity of 37.85%.

What guidance has Alpha Teknova issued on next quarter's earnings?

Alpha Teknova updated its FY 2024 earnings guidance on Tuesday, March, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $35.0 million-$38.0 million, compared to the consensus revenue estimate of $41.5 million.

When did Alpha Teknova IPO?

Alpha Teknova (TKNO) raised $90 million in an IPO on Friday, June 25th 2021. The company issued 6,000,000 shares at $14.00-$16.00 per share.

Who are Alpha Teknova's major shareholders?

Alpha Teknova's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Balyasny Asset Management L.P. (3.55%), Platinum Investment Management Ltd. (2.50%), Vanguard Group Inc. (1.34%), Vanguard Group Inc. (0.97%), Parkman Healthcare Partners LLC (0.96%) and Conestoga Capital Advisors LLC (0.84%). Insiders that own company stock include Damon Terrill, J Matthew Mackowski, Ken Gelhaus, Lisa Hood, Matthew Lowell, Stephen Gunstream, Ted Davis and Telegraph Hill Partners Iv, L.
View institutional ownership trends
.

How do I buy shares of Alpha Teknova?

Shares of TKNO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TKNO) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners